Literature DB >> 4424665

Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics.

R Silvestrini, O Sanfilippo, G Tedesco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4424665     DOI： 10.1002/1097-0142(197410)34:4<1252::aid-cncr2820340435>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.

Authors:  C Blomqvist; R Huuhtanen; Y Pan; T Wiklund; M Tarkkanen; M Virolainen; B Tribukait
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

2.  Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.

Authors:  B Helpap
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 3.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

5.  Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.

Authors:  R Molina; G Zanón; X Filella; F Moreno; J Jo; M Daniels; M L Latre; N Giménez; J Pahisa; M Velasco
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Ki67 immunostaining in primary breast cancer: pathological and clinical associations.

Authors:  N Bouzubar; K J Walker; K Griffiths; I O Ellis; C W Elston; J F Robertson; R W Blamey; R I Nicholson
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

7.  Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.

Authors:  M Railo; S Nordling; K von Boguslawsky; M Leivonen; L Kyllönen; K von Smitten
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

8.  Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

Authors:  R Molina; J Jo; G Zanón; X Filella; B Farrus; M Muñoz; M L Latre; J Pahisa; M Velasco; P Fernandez; J Estapé; A M Ballesta
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.